Tell a Friend

  • captcha

SLE

Currently Recruiting

 

Inclusion Summary

SLE Study 1

  • SLE ≥24 weeks prior
  • Currently receiving 1 of the following treatments:
  • oral prednisone.
  • Or any of
    – Azathioprine,
    – Antimalaria,
    – Mycophenolate mofetil,
    – mycophenolic acid,
    – methotrexate,
    – Mizoribine

No history of latent or active TB prior

Screening will assess criterias:

- ACR classification for SLE.

- BILAG-2004 Level

- SLEDAI-2K Criteria